Literature DB >> 18381509

Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.

Amanda Skog1, Marie Wahren-Herlenius, Birgitta Sundström, Katarina Bremme, Sven-Erik Sonesson.   

Abstract

OBJECTIVE: The purpose of this work was to analyze outcome with focus on growth in infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies and identify maternal factors other than the autoantibodies increasing the risk of fetal heart block. PATIENTS AND METHODS: Thirty-two pregnancies in 30 anti-Ro52-positive mothers were included. Seven fetuses developed second-degree or third-degree atrioventricular block, 8 developed first-degree atrioventricular block, and 17 had normal atrioventricular conduction, as diagnosed by using Doppler echocardiography. Three of 6 surviving fetuses with second-degree or third-degree atrioventricular block received treatment with fluorinated steroids. Two fetuses with second-degree atrioventricular block converted to first-degree atrioventricular block without any signs of progression during the study period. Maternal and longitudinal infant data were collected from planned neonatal follow-up and childhood health records from birth to 12 months of age in 31 survivors.
RESULTS: Women giving birth to infants with prenatal second-degree or third-degree atrioventricular block were older and with higher parity than those with first-degree atrioventricular block or normal atrioventricular conduction. Second-degree or third-degree atrioventricular block pregnancies were <40 completed weeks, whereas pregnancies with first-degree atrioventricular block or normal atrioventricular conduction had a normal duration. Fetuses with second-degree or third-degree atrioventricular block were retarded by -0.98 +/- 0.77 SD in weight at birth and did not show any catch-up during infancy. In contrast, fetuses with first-degree atrioventricular block or normal atrioventricular conduction had a weight reduction of -0.51 +/- 1.01 SD with a catch-up during the first months after birth.
CONCLUSIONS: This report documents that newborns with autoantibody-mediated second-degree or third-degree atrioventricular block are retarded in growth, with no catch-up during infancy, whereas fetuses with first-degree atrioventricular block or normal atrioventricular conduction have a normal growth soon after birth. Increased maternal age and/or parity seem to carry an increased risk for fetal heart block.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381509     DOI: 10.1542/peds.2007-1659

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  Fetal cardiac arrhythmia detection and in utero therapy.

Authors:  Janette F Strasburger; Ronald T Wakai
Journal:  Nat Rev Cardiol       Date:  2010-05       Impact factor: 32.419

Review 2.  Overview of fetal arrhythmias.

Authors:  Shardha Srinivasan; Janette Strasburger
Journal:  Curr Opin Pediatr       Date:  2008-10       Impact factor: 2.856

3.  Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study.

Authors:  Deborah M Friedman; Mimi Y Kim; Joshua A Copel; Carolina Llanos; Claudine Davis; Jill P Buyon
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

Review 4.  Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.

Authors:  Aurélie Ambrosi; Marie Wahren-Herlenius
Journal:  Arthritis Res Ther       Date:  2012-04-26       Impact factor: 5.156

Review 5.  Atrioventricular block during fetal life.

Authors:  Lindsey E Hunter; John M Simpson
Journal:  J Saudi Heart Assoc       Date:  2014-07-10

Review 6.  Fetal cardiac arrhythmias: Current evidence.

Authors:  Nathalie Jeanne Bravo-Valenzuela; Luciane Alves Rocha; Luciano Marcondes Machado Nardozza; Edward Araujo Júnior
Journal:  Ann Pediatr Cardiol       Date:  2018 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.